Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
A.MalurP
Interferon Alpha (IFN-A) and low dose cytosine arabinoside (ARA-C) therapy in Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML)
With low levels, you have a risk of building additional oxidative damage, which can contribute to wrinkles and poor skin elasticity
No evidence suggests harm, but definitive evidence of long-term safety does not exist either
The novel arsenical Darinaparsin circumvents Brg1-dependent, Ho-1-mediated cytoprotection in leukemic cells
US$ 29.21
US$ 29.48
US$ 26.95
